Open-label and non-randomized study of therapeutic effect of amantadine monotherapy and concomitant amantadine with salvia miltiorrhiza compound or selegiline on early Parkinson's disease

doi:10.3969/j.issn.1006-9771.2004.07.017

Home>Articles>Open-label and non-randomized study of therapeutic effect of amantadine monotherapy and concomitant amantadine with salvia miltiorrhiza compound or selegiline on early Parkinson's disease

DOI: 10.3969/j.issn.1006-9771.2004.07.017

Open-label and non-randomized study of therapeutic effect of amantadine monotherapy and concomitant amantadine with salvia miltiorrhiza compound or selegiline on early Parkinson's disease

Machine-generated Keywords：

Publication Date：2004-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：3( 418-420 )

CHINESE JOURNAL OF REHABILITATION THEORY AND PRACTICE

PKUISTIC

ISSN：1006-9771

Year, Vol.(Issue)：2004,10(7)